Tacrine 321-64-2 321-64-2

Tacrine is a parasympathomimetic and a centrally acting cholinesterase inhibitor (anticholinesterase). It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was marketed under the trade name Cognex. Tacrine was first synthesised by Adrien Albert at the University of Sydney.

Systematic (IUPAC) name:
Tacrine 321-64-2 CAS number:	321-64-2
ATC code:
PubChem:
DrugBank:
Formula:
Molecular mass:	g/mol
Tacrine 321-64-2 Assay/Purity:	Typically NLT 98%

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.